GOCOVRI
- Product NDC
- 70482-170
- 11-digit product format
- 704820170
- Labeler code
- 70482
- Product ID
- 70482-170_41c15d67-44b5-5c87-e063-6294a90adcc8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- AMANTADINE
- Dosage form
- CAPSULE, COATED PELLETS
- Route
- ORAL
- Labeler
- Adamas Pharma, LLC
- Application
- NDA208944
- Marketing category
- NDA
- Marketing start
- 2017-08-24
- Substance
- AMANTADINE
- Active strength
- 137 mg/1
- Pharmacologic classes
- Influenza A M2 Protein Inhibitor [EPC], M2 Protein Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- GOCOVRI
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| AMANTADINE | 137 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | BF4C9Z1J53 |
| Rxcui | 1944370, 1944376, 1944380, 1944382 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 70482-170-21 | 2024-02-08 | C162847 | 48780-1 | 1030e365-2f06-111a-e063-dadaa90a10e2 | GOCOVRI ® - These highlights do not include all the information needed to use GOCOVRI ® safely and effectively. See full prescribing information for GOCOVRI. GOCOVRI ® (amantadine) extended-release capsules, for oral use Initial U.S. Approval: 1968 |
| 70482-170-21 | 2024-02-08 | C162847 | 48780-1 | 1030e365-2f06-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use GOCOVRI ® safely and effectively. See full prescribing information for GOCOVRI ® . GOCOVRI ® (amantadine) extended-release capsules, for oral use Initial U.S. Approval: 1968 |
| 70482-170-60 | 2024-02-08 | C162847 | 48780-1 | 1030e365-2f06-111a-e063-dadaa90a10e2 | GOCOVRI ® - These highlights do not include all the information needed to use GOCOVRI ® safely and effectively. See full prescribing information for GOCOVRI. GOCOVRI ® (amantadine) extended-release capsules, for oral use Initial U.S. Approval: 1968 |
| 70482-170-60 | 2024-02-08 | C162847 | 48780-1 | 1030e365-2f06-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use GOCOVRI ® safely and effectively. See full prescribing information for GOCOVRI ® . GOCOVRI ® (amantadine) extended-release capsules, for oral use Initial U.S. Approval: 1968 |
| 70482-170-61 | 2024-02-08 | C162847 | 48780-1 | 1030e365-2f06-111a-e063-dadaa90a10e2 | GOCOVRI ® - These highlights do not include all the information needed to use GOCOVRI ® safely and effectively. See full prescribing information for GOCOVRI. GOCOVRI ® (amantadine) extended-release capsules, for oral use Initial U.S. Approval: 1968 |
| 70482-170-61 | 2024-02-08 | C162847 | 48780-1 | 1030e365-2f06-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use GOCOVRI ® safely and effectively. See full prescribing information for GOCOVRI ® . GOCOVRI ® (amantadine) extended-release capsules, for oral use Initial U.S. Approval: 1968 |
| 70482-170-21 | 2024-01-30 | C162847 | 48780-1 | 1030e365-2f06-111a-e063-dadaa90a10e2 | GOCOVRI ® - These highlights do not include all the information needed to use GOCOVRI ® safely and effectively. See full prescribing information for GOCOVRI. GOCOVRI ® (amantadine) extended-release capsules, for oral use Initial U.S. Approval: 1968 |
| 70482-170-21 | 2024-01-30 | C162847 | 48780-1 | 1030e365-2f06-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use GOCOVRI ® safely and effectively. See full prescribing information for GOCOVRI ® . GOCOVRI ® (amantadine) extended-release capsules, for oral use Initial U.S. Approval: 1968 |
| 70482-170-60 | 2024-01-30 | C162847 | 48780-1 | 1030e365-2f06-111a-e063-dadaa90a10e2 | GOCOVRI ® - These highlights do not include all the information needed to use GOCOVRI ® safely and effectively. See full prescribing information for GOCOVRI. GOCOVRI ® (amantadine) extended-release capsules, for oral use Initial U.S. Approval: 1968 |
| 70482-170-60 | 2024-01-30 | C162847 | 48780-1 | 1030e365-2f06-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use GOCOVRI ® safely and effectively. See full prescribing information for GOCOVRI ® . GOCOVRI ® (amantadine) extended-release capsules, for oral use Initial U.S. Approval: 1968 |
| 70482-170-61 | 2024-01-30 | C162847 | 48780-1 | 1030e365-2f06-111a-e063-dadaa90a10e2 | GOCOVRI ® - These highlights do not include all the information needed to use GOCOVRI ® safely and effectively. See full prescribing information for GOCOVRI. GOCOVRI ® (amantadine) extended-release capsules, for oral use Initial U.S. Approval: 1968 |
| 70482-170-61 | 2024-01-30 | C162847 | 48780-1 | 1030e365-2f06-111a-e063-dadaa90a10e2 | These highlights do not include all the information needed to use GOCOVRI ® safely and effectively. See full prescribing information for GOCOVRI ® . GOCOVRI ® (amantadine) extended-release capsules, for oral use Initial U.S. Approval: 1968 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70482-170-21 | GOCOVRI | 21 in 1 BOTTLE | CAPSULE, COATED PELLETS | 21 | | 17 |
| 70482-170-60 | GOCOVRI | 60 in 1 BOTTLE | CAPSULE, COATED PELLETS | 60 | | 17 |
| 70482-170-61 | GOCOVRI | 60 in 1 BOTTLE | CAPSULE, COATED PELLETS | 60 | | 17 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70482-170 | GOCOVRI (AMANTADINE) CAPSULE, COATED PELLETS [ADAMAS PHARMA, LLC] | 13 | Current NDC, Legacy NDC, 3 package rows | 20241012_82ff865f-78f3-4c94-b6a9-727a54944b28.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70482-170-21 | 70482017021 | 21 CAPSULE, COATED PELLETS in 1 BOTTLE (70482-170-21) | 2017-08-24 | 0000-00-00 | Yes | No | Current |
| 70482-170-60 | 70482017060 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (70482-170-60) | 2017-08-24 | 0000-00-00 | No | No | Current |
| 70482-170-61 | 70482017061 | 60 CAPSULE, COATED PELLETS in 1 BOTTLE (70482-170-61) | 2017-08-24 | 0000-00-00 | Yes | No | Current |